Most Popular Choices
Share on Facebook 35 Printer Friendly Page More Sharing Summarizing
Sci Tech    H4'ed 2/9/14  

Intravenous Vitamin C may boost chemotherapy

Quicklink Submitted By   1 comment

Dennis Kaiser
Follow Me on Twitter     Message Dennis Kaiser
Become a Fan
  (39 fans)
Image created from image crediting, From Images
Image created from image crediting
(Image by Unknown Owner)
  Details   DMCA
"Patients are looking for safe and low-cost choices in their management of cancer," she told BBC News. "Intravenous vitamin C has that potential based on our basic science research and early clinical data."

One potential hurdle is that pharmaceutical companies are unlikely to fund trials of intravenous vitamin C because there is no ability to patent natural products.

"Because vitamin C has no patent potential, its development will not be supported by pharmaceutical companies," said lead researcher Qi Chen.

"We believe that the time has arrived for research agencies to vigorously support thoughtful and meticulous clinical trials with intravenous vitamin C."
Read the rest of the story HERE:

At www.bbc.co.uk
Must Read 1   News 1   Supported 1  
Rate It | View Ratings

Dennis Kaiser Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Dennis Kaiser is an author and consultant focusing on individual rights. As a US citizen Dennis is deeply concerned over how our nation has fallen from being productive and full of hope to one where that hope is being stripped from the majority (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Follow Me on Twitter     Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter

Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation:

Tell A Friend